New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers
Abstract Cisplatin is the first and most widely used platinum-based chemotherapy drug and is the cornerstone agent in treating a broad spectrum of cancers. However, its clinical application is often limited by severe toxic side effects and drug resistance. Based on the discovered dissociative electr...
Main Authors: | Qinrong Zhang, Qing-Bin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-80876-z |
Similar Items
-
Cisplatin, Etoposide, and Vincristine Combination Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
by: SAITO, HIDEHIKO, et al.
Published: (1993) -
Study of lotus seedpod extracts in combination with chemotherapy drug cisplatin in treatment of head and neck cancer
by: Tzu-Chiao Chang, et al.
Published: (2018) -
Nedaplatin: a cisplatin derivative in cancer chemotherapy
by: Shimada M, et al.
Published: (2013-05-01) -
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
by: Kim Hyeong, et al.
Published: (2010-10-01) -
THE CLINICAL AND HISTOPATHOLOGICAL EFFECTS OF COMBINED CHEMOTHERAPY USING CISPLATIN AND PEPLOMYCIN TO TREAT CANCER OF THE TONGUE
by: UEDA, MINORU, et al.
Published: (1995)